Skip to Content

734 Endo (Mycophenolate Mofetil 250 mg)

Pill with imprint 734 Endo is Blue & Orange, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Endo Pharmaceuticals Inc..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; autoimmune hepatitis; organ transplant, rejection prophylaxis; bullous pemphigoid; graft-versus-host disease (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 734 Endo

Mycophenolate Mofetil

Imprint:
734 Endo
Strength:
250 mg
Color:
Blue & Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Endo Pharmaceuticals Inc.
Inactive Ingredients:
ammonia
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
potassium hydroxide
povidone
propylene glycol
shellac
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide